Abril, Laura
479  results:
Search for persons X
?
1

Efficacy and safety of mRNA1273 SARS-CoV-2 vaccination in h..:

Huguet, Maria ; Boigues, Marc ; Sorigué, Marc...
Medicina Clínica (English Edition).  162 (2024)  7 - p. 313-320 , 2024
 
?
2

P-203: Early mortality and treatment discontinuation in mul..:

Oriol, Albert ; Canelo-Vilaseca, Marta ; Sanchez, Carla...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S146-S147 , 2022
 
?
3

The role of idecabtagene vicleucel in patients with heavily..:

Oriol, Albert ; Abril, Laura ; Torrent, Anna..
Therapeutic Advances in Hematology.  12 (2021)  - p. 204062072110196 , 2021
 
?
4

Dose intensity and treatment duration of bortezomib in tran..:

Ibarra, Gladys ; Peña, Marta ; Abril, Laura...
European Journal of Haematology.  107 (2021)  2 - p. 246-254 , 2021
 
?
6

Response to First Cycle Is the Major Predictor of Long-Term..:

Gassiot, Susanna ; González, Yolanda ; Morgades, Mireia...
Clinical Lymphoma Myeloma and Leukemia.  19 (2019)  9 - p. 585-592.e1 , 2019
 
?
7

Impact on efficacy of the dose and schedule of bortezomib i..:

Ibarra, Gladys ; Abril, Laura ; Peña, Marta.
Clinical Lymphoma Myeloma and Leukemia.  19 (2019)  10 - p. e235 , 2019
 
?
8

Bortezomib-Dexamethasone vs Bortezomib-Dexamethasone and ch..:

Abril, Laura ; Peña, Marta ; Ibarra, Gladys..
Clinical Lymphoma Myeloma and Leukemia.  19 (2019)  10 - p. e215 , 2019
 
?
10

Evaluación de tres métodos de secado en champiñones varieda..:

Enríquez Pico, Juan ; Ramos Jaramillo, Fernanda ; Abril Carvajal, Laura
Revista Científica Arbitrada Multidisciplinaria PENTACIENCIAS.  5 (2023)  4 - p. 50-57 , 2023
 
1-15